Novo Nordisk A/S

NVO

$59.02

Name : Novo Nordisk A/S

Sector : Healthcare

Industry: Drug Manufacturers - General

Mark. Cap: $261,859,999,744.00

EPSttm : 3.91

Novo Nordisk A/S

$59.02

1.06%

$0.63

Float Short %

0.85

Margin Of Safety %

Put/Call OI Ratio

0.76

EPS Next Q Diff

5.24

EPS Last/This Y

20.17

EPS This/Next Y

1.39

Price

59.04

Target Price

70.77

Analyst Recom

2.03

Performance Q

-15.31

Relative Volume

0.55

Beta

0.66

Ticker: NVO

22 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-09-08	NVO	54.27	0.80	0.51	1152827
2025-09-09	NVO	54.15	0.80	0.52	1165607
2025-09-10	NVO	54.38	0.80	0.45	1183664
2025-09-11	NVO	54.29	0.80	0.78	1196762
2025-09-12	NVO	54.93	0.81	0.72	1211637
2025-09-15	NVO	55.88	0.78	0.50	1175035
2025-09-16	NVO	57.2	0.79	0.68	1188229
2025-09-17	NVO	58.2	0.79439609236234	0.29750971542094	1212294
2025-09-18	NVO	61.84	0.79	0.44	1222957
2025-09-19	NVO	61.56	0.80	0.53	1245598
2025-09-22	NVO	60.74	0.78	0.43	1059152
2025-09-23	NVO	59.44	0.77	0.55	1085469
2025-09-24	NVO	58.74	0.76	0.39	1102228
2025-09-25	NVO	56.08	0.77	0.95	1116257
2025-09-26	NVO	55.6	0.79	0.92	1163659
2025-09-29	NVO	55.5	0.81	0.53	1166471
2025-09-30	NVO	55.41	0.80	0.63	1226165
2025-10-01	NVO	59.11	0.79	0.26	1257392
2025-10-02	NVO	58.74	0.78	0.46	1300567
2025-10-03	NVO	59.6	0.78	0.35	1337653
2025-10-06	NVO	59.71	0.76	0.31	1292418
2025-10-07	NVO	59.11	0.76	0.61	1309594
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-09-08	NVO	54.28	-3.7	-490.8	24.84
2025-09-09	NVO	54.30	-3.7	-292.8	24.84
2025-09-10	NVO	54.38	-3.7	270.0	24.84
2025-09-11	NVO	54.30	-3.7	-553.7	24.84
2025-09-12	NVO	54.92	-3.7	-281.7	24.84
2025-09-15	NVO	55.61	-12.8	740.4	24.43
2025-09-16	NVO	57.20	-12.8	588.3	24.43
2025-09-17	NVO	58.19	-12.8	724.4	24.43
2025-09-18	NVO	61.84	-12.8	1475.1	24.23
2025-09-19	NVO	61.40	-12.8	-68.6	24.23
2025-09-22	NVO	60.71	-12.8	-95.7	24.28
2025-09-23	NVO	59.53	-12.8	-221.5	24.28
2025-09-24	NVO	58.73	-12.8	-75.6	24.28
2025-09-25	NVO	56.04	-12.8	-921.8	24.28
2025-09-26	NVO	55.61	-12.8	-474.6	24.28
2025-09-29	NVO	55.51	-12.8	268.9	24.28
2025-09-30	NVO	55.49	-12.8	68.2	24.28
2025-10-01	NVO	59.17	-19.6	2004.6	23.93
2025-10-02	NVO	58.77	-19.6	-	23.93
2025-10-03	NVO	59.64	-19.5	-	23.94
2025-10-06	NVO	59.67	-28.3	-269.7	23.94
2025-10-07	NVO	59.04	-28.3	-968.8	23.74
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-09-08	NVO	0	-5.12	0.62
2025-09-09	NVO	0	-5.12	0.62
2025-09-10	NVO	0	-5.12	0.62
2025-09-11	NVO	0	-5.12	0.77
2025-09-12	NVO	0	-5.12	0.77
2025-09-15	NVO	0	-5.67	0.77
2025-09-16	NVO	0	-5.67	0.77
2025-09-17	NVO	0	-5.67	0.77
2025-09-18	NVO	0	-5.67	0.77
2025-09-19	NVO	0	-5.67	0.77
2025-09-22	NVO	0	-5.63	0.77
2025-09-23	NVO	0	-5.63	0.77
2025-09-24	NVO	0	-5.63	0.77
2025-09-25	NVO	0	-5.63	0.85
2025-09-26	NVO	0	-5.63	0.85
2025-09-29	NVO	0	-6.22	0.85
2025-09-30	NVO	0	-6.22	0.85
2025-10-01	NVO	0	-6.22	0.85
2025-10-02	NVO	0	-6.22	0.85
2025-10-03	NVO	0	-6.22	0.85
2025-10-06	NVO	0	-1.45	0.85
2025-10-07	NVO	0	-1.45	0.85
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

0.97

Avg. EPS Est. Current Quarter

4.92

Avg. EPS Est. Next Quarter

6.21

Insider Transactions

Institutional Transactions

-1.45

Beta

0.66

Average Sales Estimate Current Quarter

76582

Average Sales Estimate Next Quarter

81255

Fair Value

61.49

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

60.2

Max Drawdown 5-Year %

-68.5

Target Price

70.77

P/E

16.26

Forward P/E

14.32

PEG

1.34

P/S

4.37

P/B

9.91

P/Free Cash Flow

20.94

EPS

3.63

Average EPS Est. Cur. Y

23.74

EPS Next Y. (Est.)

25.12

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

35.6

Relative Volume

0.55

Return on Equity vs Sector %

40.9

Return on Equity vs Industry %

32.3

EPS 1 7Days Diff

-0.6

EPS 1 30Days Diff

-1.1

EBIT Estimation

-968.8

Novo Nordisk A/S

Sector: Healthcare

Industry: Drug Manufacturers - General

Employees: 78387

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with UNICEF to tackle childhood obesity; and with Valo Health, Inc. to discover and develop novel drug programmes for cardiometabolic space. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

stock quote shares NVO – Novo Nordisk A/S Stock Price stock today

news today NVO – Novo Nordisk A/S stock forecast ,stock prediction 2023 2024 2025

marketwatch NVO – Novo Nordisk A/S yahoo finance google finance

stock history NVO – Novo Nordisk A/S invest stock market

stock prices NVO premarket after hours

ticker NVO fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: NVO

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y